- Report
- September 2025
- 250 Pages
Global
From €3927EUR$4,490USD£3,389GBP
- Report
- October 2025
- 160 Pages
Global
From €3455EUR$3,950USD£2,981GBP
- Report
- August 2025
- 194 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- August 2025
- 189 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- February 2026
- 462 Pages
Global
From €5117EUR$5,850USD£4,415GBP
- Report
- December 2025
- 150 Pages
Global
From €3367EUR$3,850USD£2,906GBP
€4242EUR$4,850USD£3,660GBP
- Report
- November 2025
- 150 Pages
Global
From €3367EUR$3,850USD£2,906GBP
€4242EUR$4,850USD£3,660GBP
- Report
- January 2026
- 186 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- January 2026
- 197 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- January 2026
- 189 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- January 2026
- 193 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- January 2026
- 193 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- September 2025
- 150 Pages
Global
From €5204EUR$5,950USD£4,490GBP
- Report
- January 2026
- 183 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- February 2026
- 218 Pages
Global
From €5117EUR$5,850USD£4,415GBP
- Report
- February 2026
- 381 Pages
Global
From €5117EUR$5,850USD£4,415GBP
- Report
- December 2025
- 250 Pages
Global
From €3927EUR$4,490USD£3,389GBP
- Report
- December 2025
- 250 Pages
Global
From €3927EUR$4,490USD£3,389GBP
- Report
- July 2025
- 175 Pages
Global
From €3927EUR$4,490USD£3,389GBP
- Report
- July 2025
- 175 Pages
Global
From €3927EUR$4,490USD£3,389GBP

Polyclonal antibodies are a type of immune disorder drug used to treat a variety of conditions, including autoimmune diseases, allergies, and cancer. These drugs are made up of a mixture of antibodies that are produced by the body in response to a foreign substance, such as a virus or bacteria. They work by targeting and neutralizing the foreign substance, thus preventing it from causing further damage. Polyclonal antibodies can be administered intravenously, intramuscularly, or subcutaneously.
Polyclonal antibodies are used to treat a variety of conditions, including rheumatoid arthritis, multiple sclerosis, Crohn's disease, and psoriasis. They are also used to treat certain types of cancer, such as lymphoma and leukemia. In addition, polyclonal antibodies are used to treat allergies, such as hay fever and asthma.
The polyclonal antibodies market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more